Anthropic Drives Rare Disease Research with AI Credits as NVIDIA Unveils Cosmos 3 Edge, an Advanced Multimodal Model

What happened

Anthropic announced a grant program offering up to $50,000 in usage credits for their Claude model aimed at researchers working to accelerate the development of treatments for rare diseases. This initiative is part of their "AI for Science" program, which supports scientific projects using AI to speed up discovery.

Meanwhile, NVIDIA unveiled its new foundational model Cosmos 3 Edge, which combines autoregressive and diffusion architectures with transformer towers and shared multimodal attention. This model integrates capabilities for understanding, prediction, simulation, and action into a single platform, expanding the functionality and reach of current artificial intelligence models.

Additionally, Satya Nadella, CEO of Microsoft, confirmed that "it's okay now" in a post, although he did not specify exactly what he was referring to in this context, leaving it open to interpretation.

Why it matters

Anthropic's initiative represents a significant step in the direct application of foundational AI models to advance medicine, particularly in a complex area like rare diseases that often have limited resources and lengthy research processes. Providing usage credits for models like Claude enables researchers to experiment and accelerate developments without facing the typical economic barriers to accessing advanced technology.

With Cosmos 3 Edge, NVIDIA not only expands its portfolio of AI solutions but also promotes a multimodal approach that allows a single model to handle multiple tasks and data types simultaneously (text, image, simulation, prediction). This technological convergence could transform sectors such as robotics, complex systems analysis, and advanced automation, bringing AI closer to applications with greater autonomy and integration.

What remains to be confirmed

Although Anthropic has launched this grant program, the selection processes and specific fields within rare diseases that will be prioritized have not yet been detailed. The total volume of resources allocated to this program and the expected short- or medium-term outcomes are also unconfirmed.

Regarding Cosmos 3 Edge, while a technical breakdown is available, the actual adoption of the model and its performance in practical applications remain to be verified. There is no public information about immediate strategic partnerships or a timeline for commercial implementations.

Finally, Satya Nadella's brief statement lacks context for clear interpretation and cannot be considered confirmation of any development or technological status.

### Disclaimer This article is based exclusively on public posts on X/Twitter from Anthropic, NVIDIA, and Satya Nadella, without additional sources or external confirmations. The information is subject to verification and evolution as official updates or results from these projects are published. It does not constitute financial advice or investment recommendation.

### Sources - AnthropicAI - Grants in credits for researchers - NVIDIAAI - Cosmos 3 Edge presentation - NVIDIAAI - Related post - Satya Nadella - Brief message